Chairman of the Board
Mr. Auberton-Herve is the founder of 4A Consulting & Engineering ("4A Consulting"), which provides strategic advice and consulting services with respect to renewable energy and digital innovation, and has served as its President and CEO since its founding in July 2015. 4A Consulting has been providing consulting services to the Company since February 2017. Mr. Auberton-Herve co-founded Soitec SA, a publicly traded company on the Euronext Paris stock exchange which designs and manufactures innovative semiconductor materials which are used in many smartphone platforms and computing activities, where he was President and CEO from July 1992 until January 2015, then Chairman and Chairman Emeritus since September 2015.
While at Soitec SA, Mr. Auberton-Herve was responsible for overseeing the strategic, operational and financial activities of the company. He built an international high-tech group in ten countries and five manufacturing facilities in Europe, Asia and the U.S. Mr. Auberton-Herve also led the company through its listing on Euronext in 1999, raising more than $1 billion since then with some of the world's largest investment banks. He has been nominated Knight of the Legion of Honor and Knight of the Order of Merit in France. Mr. Auberton-Herve holds a Doctorate degree in Semiconductor Physics and a Master's degree in Materials Science from Ecole Centrale de Lyon in France. The Company believes that Mr. Auberton-Herve is qualified as a board member of the Company because of his substantial strategic, operational and leadership experience.
Mr. Dreyfus has been a Director of the Company since September 1, 2017. Mr. Dreyfus has also served as a board member of Christie’s in Paris since 2014. Mr. Dreyfus has been the CEO and Founder of RGD Investissements S.A.S in Paris, a developer and investor in real estate assets in Paris, since 2007. Prior to 2007, Mr. Dreyfus was a shareholder, Chairman and CEO of the Photo-journalism group A.G.I. (including Gamma Press Agency). Mr. Dreyfus was a co-founder of a Parisian law firm in 1984, and was a lawyer in France until 1992.
Mr. Martin currently serves as Chairman of Brooks Automation, a global provider of automation, vacuum and instrumentation solutions. He also serves as a director of Collectors Universe, Inc., a third-party grading and authentication service for high-value collectibles, and of Allegro Microsystems, a manufacturer of high-performance semiconductors for the automotive, green energy and consumer electronics markets. He has served on the boards of multiple publicly traded companies including Collectors Universe, Inc., Fairchild Semiconductor, ChipPAC Inc. and Soitec Inc. In 2000 CFO Magazine awarded Mr. Martin the CFO of the Year award for turnaround operations.
Mr. Matine is founder and CEO of B&Associates, a marketing and digital transformation company, and also is a strategic advisor to C4 Ventures and an Advisory Board Member for Enlaps. He previously spent eight years with Apple France where he led the Education and Research business unit, and Apple Europe, where he was responsible for promoting Apple products and defining marketing, PR and branding strategies within central Europe, the Middle East and Africa. Prior to Apple, Matine worked extensively in marketing and advertising, promoting technology products and brands throughout Europe.
Matine studied at Sciences Po (the Paris Institute for Political Studies, Section Public Service) and holds the IFA-Sciences Po non-executive director certificate. His experience with product marketing and go-to-market strategies is expected to be impactful as BIONIK prepares to expand its product line to consumer markets and broaden its sales distribution to additional geographies.
Mr. Prywata is the co-founder and Chief Technology Officer of BIONIK Laboratories. He studied biomedical engineering at Ryerson University and has a proven track record of inventing and winning technology showcases. While attending Ryerson, Mr. Prywata co-invented the world’s first robotic, prosthetic arm that is controlled by brain signals. Equally impressive is his strong understanding of developing technologies that address significant and untapped markets. He is responsible for raising the initial capital to found BIONIK and turn numerous concepts into products.
Audrey D. Thévenon, Ph.D.
Dr. Thévenon is a Program Officer on the Board of Life Sciences at The National Academies of Sciences, Engineering and Medicine, where she also serves as the Managing Editor of the journal Institute for Laboratory Animal Research. Since joining the Academies, Dr. Thévenon has supported collaborative regional and international activities aimed at promoting transdisciplinary research. Prior to the Academies, Dr. Thévenon completed a Postdoctoral Fellowship at the University of Hawaii in placental pharmacology, followed by another fellowship at Uniformed Services University of the Health Sciences in Bethesda, Md. working on two PEPFAR-funded HIV-Malaria projects in collaboration with Nigeria and Kenya.
Dr. Thévenon has a Ph.D. and an MS, both in Biology, from Georgetown University, as well as an MS in Cell Biology & Physiology and a BS in Life Sciences and Environment from the University of Rennes 1 in France. BIONIK believes that Dr. Thévenon's experience in medicine and scientific innovation will enable BIONIK to further its connection with the most advanced bioscience research around the world.